Trial Title:
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
NCT ID:
NCT03768063
Condition:
Cancer
Conditions: Official terms:
Bevacizumab
Pembrolizumab
Pemetrexed
Atezolizumab
Venetoclax
Sunitinib
Niraparib
Vemurafenib
Rucaparib
Alectinib
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Drug
Intervention name:
Atezolizumab
Description:
Atezolizumab will be administered as a monotherapy or atezolizumab with other agent(s) as
per parent protocol. Dosing regimen will continue in accordance with the parent study or
at equivalent dose (if applicable) and at the same schedule as the parent study, or
switch to a fixed atezolizumab dose of 1200 mg every 3 weeks (Q3W).
Arm group label:
Atezolizumab Monotherapy
Arm group label:
Combined Agents with Atezolizumab
Other name:
Tecentriq
Intervention type:
Drug
Intervention name:
Bevacizumab
Description:
Bevacizumab will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Other name:
Avastin
Intervention type:
Drug
Intervention name:
Alectinib
Description:
Alectinib will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Other name:
Alecensa
Intervention type:
Drug
Intervention name:
Cobimetinib
Description:
Cobimetinib will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Other name:
Cotellic
Intervention type:
Drug
Intervention name:
Vemurafenib
Description:
Vemurafenib will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Other name:
Zelboraf
Intervention type:
Drug
Intervention name:
FAP IL2V
Description:
FAP IL2V will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Other name:
simlukafusp alfa
Intervention type:
Drug
Intervention name:
Venetoclax
Description:
Venetoclax will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Other name:
Venclexta
Intervention type:
Drug
Intervention name:
Enzalutamide
Description:
Enzalutamide will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Other name:
Xtandi
Intervention type:
Drug
Intervention name:
Pembrolizumab
Description:
Pembrolizumab will be administered as directed per the parent study.
Arm group label:
Comparator Treatment
Other name:
Keytruda
Intervention type:
Drug
Intervention name:
Sunitinib
Description:
Sunitinib will be administered as directed per the parent study.
Arm group label:
Comparator Treatment
Other name:
Sutent
Intervention type:
Drug
Intervention name:
Niraparib
Description:
Niraparib will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Other name:
Zejula
Intervention type:
Drug
Intervention name:
Cabozantinib
Description:
Cabozantinib will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Other name:
Cometriq
Intervention type:
Drug
Intervention name:
Pemetrexed
Description:
Pemetrexed will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Intervention type:
Drug
Intervention name:
Paclitaxel
Description:
Paclitaxel will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Arm group label:
Comparator Treatment
Intervention type:
Drug
Intervention name:
Emactuzumab
Description:
Emactuzumab will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Intervention type:
Drug
Intervention name:
Rucaparib
Description:
Rucaparib will be administered as directed per the parent study.
Arm group label:
Combined Agents with Atezolizumab
Summary:
This is an open-label, multicenter, extension study. Patients who are receiving clinical
benefit from atezolizumab monotherapy or atezolizumab in combination with other agent(s)
or combination/comparator agent(s) during participation in a Genentech or Roche-sponsored
study (the parent study), who are eligible to continue treatment and who do not have
access to the study treatment locally, may continue to receive study treatment in this
extension study following roll-over from the parent study.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Eligible for continuing atezolizumab-based therapy at the time of roll-over from the
parent study, as per the parent study protocol or
- Eligible for continuing the comparator agent(s) in a Genentech- or Roche-sponsored
study as per the parent study protocol, with no access to commercially available
comparator agent
- Time between the last dose of treatment received in parent study and first dose in
extension study is no longer than the interruption period allowed in the parent
study. First dose of study treatment in this extension study will be received within
7 days of the treatment interruption window allowed by the parent study
- Continue to benefit from atezolizumab-based study treatment or from the comparator
at the time of roll-over from the parent study as assessed by the investigator
- Negative serum pregnancy test within 7 days prior to start of study treatment in
women of childbearing potential
- For women of childbearing potential: agreement to remain abstinent or use
contraceptive methods, and agreement to refrain from donating eggs
- For men: agreement to remain abstinent or use contraceptive measures, and agreement
to refrain from donating sperm
Exclusion Criteria:
- Meet any of the study treatment discontinuation criteria specified in the parent
study at the time of enrollment in this extension study
- Study treatment or comparator agent is commercially marketed in the patient's
country for the patient-specific disease and is accessible to the patient
- Treatment with any anti-cancer treatment during the time between last treatment in
the parent study and the first dose of study treatment in this extension study
- Permanent discontinuation of atezolizumab for any reason during the parent study or
during the time between last treatment in the parent study and the first dose of
study treatment in this extension study (if applicable). Exception: Participants who
permanently discontinued atezolizumab from parent studies that permit participants
to continue treatment with the combination agent(s) alone after permanently
discontinuing atezolizumab are eligible to enroll in this study.
- Ongoing serious adverse event(s) that has not resolved to baseline level or Grade ≤1
from the parent study or during the time between the last treatment in the parent
study and the first dose of study treatment in this extension study
- Any condition that, in the opinion of the investigator, would interfere with the
interpretation of patient safety or place the patient at high risk for
treatment-related complications
- Concurrent participation in any therapeutic clinical trial (other than the parent
study)
- Pregnant or lactating, or intending to become pregnant during this extension study
and for the period after the last dose of study treatment specified in the
designated referenced safety information (RSI)
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Univ of Alabama at Birmingham; UAB Comprehensive Cancer Ctr
Address:
City:
Birmingham
Zip:
352331912
Country:
United States
Status:
Withdrawn
Facility:
Name:
HonorHealth Research Institute - Pima - Virginia G. Piper Cancer Care Network
Address:
City:
Scottsdale
Zip:
85258
Country:
United States
Status:
Completed
Facility:
Name:
University of Arkansas for Medical Sciences; Winthrop Rockefeller Cancer Institute
Address:
City:
Little Rock
Zip:
72205
Country:
United States
Status:
Withdrawn
Facility:
Name:
City of Hope
Address:
City:
Duarte
Zip:
91010
Country:
United States
Status:
Withdrawn
Facility:
Name:
UCLA Hematology / Oncology Clinic
Address:
City:
Los Angeles
Zip:
90095
Country:
United States
Status:
Completed
Facility:
Name:
Stanford University Medical Center
Address:
City:
Palo Alto
Zip:
94304
Country:
United States
Status:
Withdrawn
Facility:
Name:
Kaiser Permanente - Bellflower
Address:
City:
San Diego
Zip:
92108
Country:
United States
Status:
Withdrawn
Facility:
Name:
University of Colorado Cancer Center
Address:
City:
Aurora
Zip:
80045
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
University of Colorado; Anschutz Cancer Pavilion
Address:
City:
Aurora
Zip:
80045
Country:
United States
Status:
Withdrawn
Facility:
Name:
Smilow Cancer Hospital at Yale New Haven
Address:
City:
New Haven
Zip:
06510
Country:
United States
Status:
Withdrawn
Facility:
Name:
Yale Cancer Center
Address:
City:
New Haven
Zip:
06520
Country:
United States
Status:
Withdrawn
Facility:
Name:
Smilow Cancer Center
Address:
City:
North Haven
Zip:
06473
Country:
United States
Status:
Withdrawn
Facility:
Name:
Yale University School Of Medicine; Yale Cancer Center
Address:
City:
Trumbull
Zip:
06611
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Medstar Georgetown University Hospital
Address:
City:
Washington
Zip:
20007
Country:
United States
Status:
Completed
Facility:
Name:
SCRI Florida Cancer Specialists South
Address:
City:
Fort Myers
Zip:
33916
Country:
United States
Status:
Withdrawn
Facility:
Name:
Mercy Hospital, a Campus of Plantation General Hospital
Address:
City:
Miami
Zip:
33133
Country:
United States
Status:
Withdrawn
Facility:
Name:
Advent Health Orlando
Address:
City:
Orlando
Zip:
32804
Country:
United States
Status:
Recruiting
Facility:
Name:
Hematology Oncology Associates of the Treasure Coast
Address:
City:
Port Saint Lucie
Zip:
34952
Country:
United States
Status:
Withdrawn
Facility:
Name:
SCRI Florida Cancer Specialists North; Research Office North Region.
Address:
City:
Saint Petersburg
Zip:
33705
Country:
United States
Status:
Withdrawn
Facility:
Name:
University Of Chicago Medical Center; Section Of Hematology/Oncology
Address:
City:
Chicago
Zip:
60637
Country:
United States
Status:
Completed
Facility:
Name:
Fort Wayne Medical Oncology and Hematology, Inc
Address:
City:
Fort Wayne
Zip:
46804
Country:
United States
Status:
Completed
Facility:
Name:
Barbara Ann Karmanos Cancer Institute
Address:
City:
Detroit
Zip:
48201-2013
Country:
United States
Status:
Withdrawn
Facility:
Name:
New England Cancer Specialists
Address:
City:
Scarborough
Zip:
04074
Country:
United States
Status:
Withdrawn
Facility:
Name:
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Address:
City:
Baltimore
Zip:
21287
Country:
United States
Status:
Completed
Facility:
Name:
Massachusetts General Hospital
Address:
City:
Boston
Zip:
02114-2621
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Massachusetts General Hospital
Address:
City:
Boston
Zip:
02114
Country:
United States
Status:
Withdrawn
Facility:
Name:
Beth Israel Deaconess Medical Center
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Terminated
Facility:
Name:
Dana Farber Cancer Institute
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Completed
Facility:
Name:
Dana Farber Cancer Institute
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Withdrawn
Facility:
Name:
St. Joseph Mercy Hospital; Cancer Care Center.
Address:
City:
Ann Arbor
Zip:
48106
Country:
United States
Status:
Withdrawn
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Withdrawn
Facility:
Name:
Montefiore Medical Center
Address:
City:
Bronx
Zip:
10467
Country:
United States
Status:
Withdrawn
Facility:
Name:
New York University School of Medicine
Address:
City:
New York
Zip:
10016
Country:
United States
Status:
Withdrawn
Facility:
Name:
Memorial Sloan Kettering - Basking Ridge
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Withdrawn
Facility:
Name:
Levine Cancer Institute-Carolinas Medical Center
Address:
City:
Charlotte
Zip:
28204
Country:
United States
Status:
Completed
Facility:
Name:
Carolina BioOncology Institute, PLCC
Address:
City:
Huntersville
Zip:
28078
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Oncology Hematology Care Inc
Address:
City:
Cincinnati
Zip:
45242
Country:
United States
Status:
Withdrawn
Facility:
Name:
Ohio State University; Hemat/Onc
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Withdrawn
Facility:
Name:
St. Luke's Cancer Care Associates
Address:
City:
Bethlehem
Zip:
18015
Country:
United States
Status:
Terminated
Facility:
Name:
Fox Chase Cancer Center
Address:
City:
Philadelphia
Zip:
19111
Country:
United States
Status:
Withdrawn
Facility:
Name:
University of Pittsburgh Medical Center Cancer Center; Investigational Drug Service
Address:
City:
Pittsburgh
Zip:
15232
Country:
United States
Status:
Withdrawn
Facility:
Name:
Sarah Cannon Research Institute / Tennessee Oncology
Address:
City:
Chattanooga
Zip:
37404
Country:
United States
Status:
Withdrawn
Facility:
Name:
Sarah Cannon Research Institute / Tennessee Oncology
Address:
City:
Nashville
Zip:
37203
Country:
United States
Status:
Withdrawn
Facility:
Name:
SCRI Oncology Partners
Address:
City:
Nashville
Zip:
37203
Country:
United States
Status:
Completed
Facility:
Name:
SCRI Oncology Partners
Address:
City:
Nashville
Zip:
37203
Country:
United States
Status:
Withdrawn
Facility:
Name:
The University of Texas MD Anderson Cancer Center
Address:
City:
Houston
Zip:
77030-4009
Country:
United States
Status:
Completed
Facility:
Name:
University of Texas Health Sciences Center in San Antonio
Address:
City:
San Antonio
Zip:
78229
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Providence Regional Cancer Partnership
Address:
City:
Everett
Zip:
98201
Country:
United States
Status:
Withdrawn
Facility:
Name:
University of Washington - Seattle Cancer Care Alliance; Medical Oncology
Address:
City:
Seattle
Zip:
98109
Country:
United States
Status:
Withdrawn
Facility:
Name:
University of Washington - Seattle Cancer Care Alliance; Medical Oncology
Address:
City:
Seattle
Zip:
98109
Country:
United States
Status:
Completed
Facility:
Name:
Chris O'Brien Lifehouse
Address:
City:
Camperdown
Zip:
2050
Country:
Australia
Status:
Withdrawn
Facility:
Name:
St Vincent'S Hospital
Address:
City:
Darlinghurst
Zip:
2010
Country:
Australia
Status:
Terminated
Facility:
Name:
The Prince Charles Hospital; Oncology Dept.
Address:
City:
Chermside
Zip:
4032
Country:
Australia
Status:
Withdrawn
Facility:
Name:
The Townsville Hospital
Address:
City:
Douglas
Zip:
4814
Country:
Australia
Status:
Withdrawn
Facility:
Name:
Townsville Hospital
Address:
City:
Townsville
Zip:
4810
Country:
Australia
Status:
Completed
Facility:
Name:
Cabrini Hospital Malvern
Address:
City:
Malvern
Zip:
3144
Country:
Australia
Status:
Withdrawn
Facility:
Name:
UZ Brussel
Address:
City:
Brussel
Zip:
1090
Country:
Belgium
Status:
Active, not recruiting
Facility:
Name:
Institut Jules Bordet
Address:
City:
Bruxelles
Zip:
1000
Country:
Belgium
Status:
Terminated
Facility:
Name:
Universitair Ziekenhuis Gent; Oncology
Address:
City:
Gent
Zip:
9000
Country:
Belgium
Status:
Withdrawn
Facility:
Name:
UZ Leuven
Address:
City:
Leuven
Zip:
3000
Country:
Belgium
Status:
Active, not recruiting
Facility:
Name:
Hospital Araujo Jorge; Patologia
Address:
City:
Goiania
Zip:
74605-070?
Country:
Brazil
Status:
Active, not recruiting
Facility:
Name:
Instituto Nacional de Cancer - INCa; Oncologia
Address:
City:
Rio de Janeiro
Zip:
20560-120
Country:
Brazil
Status:
Completed
Facility:
Name:
Hospital das Clinicas - UFRGS
Address:
City:
Porto Alegre
Zip:
90035-903
Country:
Brazil
Status:
Completed
Facility:
Name:
Instituto do Cancer do Estado de Sao Paulo - ICESP
Address:
City:
Sao Paulo
Zip:
01246-000
Country:
Brazil
Status:
Completed
Facility:
Name:
Multiprofile Hospital for Active Treatment Central Onco Hospital OOD; Dept. of Medical Oncology
Address:
City:
Plovdiv
Zip:
4004
Country:
Bulgaria
Status:
Terminated
Facility:
Name:
Multiprofile Hospital for Active Treatment Serdika EOOD; Medical Oncology Department
Address:
City:
Sofia
Zip:
1632
Country:
Bulgaria
Status:
Withdrawn
Facility:
Name:
BC Cancer ? Vancouver
Address:
City:
Vancouver
Zip:
V5Z 4E6
Country:
Canada
Status:
Completed
Facility:
Name:
Lakeridge Health Oshawa
Address:
City:
Oshawa
Zip:
L1G 2B9
Country:
Canada
Status:
Withdrawn
Facility:
Name:
Princess Margaret Cancer Center
Address:
City:
Toronto
Zip:
M5G 1Z5
Country:
Canada
Status:
Completed
Facility:
Name:
Pontificia Universidad Catolica de Chile; Centro Del Cáncer
Address:
City:
Santiago
Zip:
8330032
Country:
Chile
Status:
Active, not recruiting
Facility:
Name:
Masaryk?v onkologický ústav; Klinika komplexní onkologické pé?e
Address:
City:
Brno
Zip:
656 53
Country:
Czechia
Status:
Active, not recruiting
Facility:
Name:
Fakultni nemocnice Olomouc; Onkologicka klinika
Address:
City:
Olomouc
Zip:
779 00
Country:
Czechia
Status:
Active, not recruiting
Facility:
Name:
Rigshospitalet; Hæmatologisk Klinik
Address:
City:
København Ø
Zip:
2100
Country:
Denmark
Status:
Withdrawn
Facility:
Name:
Rigshospitalet
Address:
City:
København Ø
Zip:
2100
Country:
Denmark
Status:
Terminated
Facility:
Name:
CHU Angers
Address:
City:
Angers
Zip:
49933
Country:
France
Status:
Active, not recruiting
Facility:
Name:
Institut Bergonie; Oncologie
Address:
City:
Bordeaux
Zip:
33076
Country:
France
Status:
Completed
Facility:
Name:
Centre Jean Perrin; Oncologie
Address:
City:
Clermont Ferrand
Zip:
63011
Country:
France
Status:
Withdrawn
Facility:
Name:
Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez
Address:
City:
Lille
Zip:
59037
Country:
France
Status:
Terminated
Facility:
Name:
Centre Leon Berard
Address:
City:
Lyon
Zip:
69008
Country:
France
Status:
Completed
Facility:
Name:
CHU Timone; Centre d'Essais Précoces en Cancérologie de Marseille (CEPCM)
Address:
City:
Marseille
Zip:
13005
Country:
France
Status:
Active, not recruiting
Facility:
Name:
Institut Régional du Cancer de Montpellier
Address:
City:
Montpellier
Zip:
34298
Country:
France
Status:
Withdrawn
Facility:
Name:
Centre Antoine Lacassagne
Address:
City:
Nice
Zip:
06189
Country:
France
Status:
Active, not recruiting
Facility:
Name:
Institut Curie; Oncologie Medicale
Address:
City:
Paris
Zip:
75231
Country:
France
Status:
Withdrawn
Facility:
Name:
APHP - Hospital Saint Louis
Address:
City:
Paris
Zip:
75475
Country:
France
Status:
Withdrawn
Facility:
Name:
Hopital d'Instruction des Armees de Begin
Address:
City:
Saint-Mande
Zip:
94160
Country:
France
Status:
Completed
Facility:
Name:
Hôpital d'Instruction des Armées de Sainte Anne; Service de Pneumologie
Address:
City:
Toulon
Zip:
83000
Country:
France
Status:
Withdrawn
Facility:
Name:
Institut Claudius Regaud; Departement Oncologie Medicale
Address:
City:
Toulouse
Zip:
31059
Country:
France
Status:
Active, not recruiting
Facility:
Name:
IUCT Oncopole
Address:
City:
Toulouse
Zip:
31100
Country:
France
Status:
Withdrawn
Facility:
Name:
Institut Gustave Roussy
Address:
City:
Villejuif
Zip:
94805
Country:
France
Status:
Active, not recruiting
Facility:
Name:
Kliniken Essen-Mitte
Address:
City:
Essen
Zip:
45136
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
St. Elisabethen Krankenhaus
Address:
City:
Frankfurt am Main
Zip:
60487
Country:
Germany
Status:
Withdrawn
Facility:
Name:
Universitätsklinikum Freiburg;Klinik für Innere Medizin I
Address:
City:
Freiburg
Zip:
79106
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
Asklepios-Fachklinik Muenchen-Gauting; Klinik Für Pneumologie
Address:
City:
Gauting
Zip:
82131
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
SRH Wald-Klinikum Gera; Zentrum fur klinische Studien (ZKS)
Address:
City:
Gera
Zip:
07548
Country:
Germany
Status:
Terminated
Facility:
Name:
Universitätsklinikum Hamburg-Eppendorf
Address:
City:
Hamburg
Zip:
20246
Country:
Germany
Status:
Withdrawn
Facility:
Name:
HOPA MVZ GmbH
Address:
City:
Hamburg
Zip:
22767
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
Universitätsklinikum Heidelberg
Address:
City:
Heidelberg
Zip:
69120
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
SLK-Kliniken Heilbronn GmbH; Klinik für Innere Medizin III; Schwerpunkt Häma./Onko./Palliativm.
Address:
City:
Heilbronn
Zip:
74078
Country:
Germany
Status:
Withdrawn
Facility:
Name:
Lungenfachklinik Immenhausen; Zentrum fur Pneumologie
Address:
City:
Immenhausen
Zip:
34376
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
BAG Prof Dr G Hoheisel Dr A Bonitz; Praxis fur Pneumologie und Allergologie
Address:
City:
Leipzig
Zip:
4275
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
Universitaetsklinikum Muenster
Address:
City:
Muenster
Zip:
48149
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
Klinikum d.Universität München Campus Großhadern
Address:
City:
München
Zip:
81377
Country:
Germany
Status:
Withdrawn
Facility:
Name:
Krankenhaus Barmherzige Bruder Regensburg
Address:
City:
Regensburg
Zip:
93049
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
Universitaets-Hautklinik Tuebingen
Address:
City:
Tübingen
Zip:
72076
Country:
Germany
Status:
Terminated
Facility:
Name:
Universitätsklinik Tübingen; Frauenklinik & Poliklinik
Address:
City:
Tübingen
Zip:
72076
Country:
Germany
Status:
Active, not recruiting
Facility:
Name:
Laiko General Hospital Athen
Address:
City:
Athens
Zip:
115 27
Country:
Greece
Status:
Terminated
Facility:
Name:
Alexandras Hospital; Dept. of Clin. Therapeutics, Athens Uni School of Medicine
Address:
City:
Athens
Zip:
115 28
Country:
Greece
Status:
Withdrawn
Facility:
Name:
Anticancer Hospital Ag. Savas
Address:
City:
Athens
Zip:
11522
Country:
Greece
Status:
Terminated
Facility:
Name:
Metropolitan Hospital
Address:
City:
Athens
Zip:
185 47
Country:
Greece
Status:
Active, not recruiting
Facility:
Name:
University General Hospital of Larissa
Address:
City:
Larissa
Zip:
412 21
Country:
Greece
Status:
Withdrawn
Facility:
Name:
University Hospital of Larissa; Oncology
Address:
City:
Larissa
Country:
Greece
Status:
Withdrawn
Facility:
Name:
Grupo Angeles
Address:
City:
Guatemala City
Zip:
01015
Country:
Guatemala
Status:
Active, not recruiting
Facility:
Name:
Queen Mary Hospital
Address:
City:
Hong Kong
Zip:
999077
Country:
Hong Kong
Status:
Completed
Facility:
Name:
Orszagos Onkologiai Intezet; "C" Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály
Address:
City:
Budapest
Zip:
1122
Country:
Hungary
Status:
Withdrawn
Facility:
Name:
Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly
Address:
City:
Budapest
Zip:
1122
Country:
Hungary
Status:
Active, not recruiting
Facility:
Name:
Országos Onkológiai Intézet; Onkológiai Képalkotó és Invazív Diagnosztikai Központ
Address:
City:
Budapest
Zip:
1122
Country:
Hungary
Status:
Completed
Facility:
Name:
Szegedi Tudomanyegyetem, AOK
Address:
City:
Budapest
Country:
Hungary
Status:
Withdrawn
Facility:
Name:
Petz Aladar Megyei Oktato Korhaz; Pulmonologiai Osztaly
Address:
City:
Gyor
Zip:
9024
Country:
Hungary
Status:
Withdrawn
Facility:
Name:
Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika
Address:
City:
Pecs
Zip:
7632
Country:
Hungary
Status:
Completed
Facility:
Name:
Szegedi Tudományegyetem; Onkoterápiás Klinika
Address:
City:
Szeged
Zip:
6720
Country:
Hungary
Status:
Completed
Facility:
Name:
Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz; Pulmonologiai Osztaly
Address:
City:
Szekesfehervar
Zip:
8001
Country:
Hungary
Status:
Completed
Facility:
Name:
Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica
Address:
City:
Milano
Zip:
20133
Country:
Italy
Status:
Terminated
Facility:
Name:
Nagoya University Hospital
Address:
City:
Aichi
Zip:
466-8560
Country:
Japan
Status:
Recruiting
Facility:
Name:
National Hospital Organization Shikoku Cancer Center
Address:
City:
Ehime
Zip:
791-0280
Country:
Japan
Status:
Active, not recruiting
Facility:
Name:
National Hospital Organization Kyushu Medical Center
Address:
City:
Fukuoka
Zip:
810-8563
Country:
Japan
Status:
Active, not recruiting
Facility:
Name:
Kyushu University Hospital
Address:
City:
Fukuoka
Zip:
812-8582
Country:
Japan
Status:
Recruiting
Facility:
Name:
Hokkaido University Hospital
Address:
City:
Hokkaido
Zip:
060-8648
Country:
Japan
Status:
Recruiting
Facility:
Name:
University of Tsukuba Hospital
Address:
City:
Ibaraki
Zip:
305-8576
Country:
Japan
Status:
Recruiting
Facility:
Name:
Kanazawa University Hospital
Address:
City:
Ishikawa
Zip:
920-8641
Country:
Japan
Status:
Active, not recruiting
Facility:
Name:
Iwate Medical University Hospital
Address:
City:
Iwate
Zip:
028-3695
Country:
Japan
Status:
Completed
Facility:
Name:
Kitasato University Hospital
Address:
City:
Kanagawa
Zip:
252-0375
Country:
Japan
Status:
Completed
Facility:
Name:
Sendai Kousei Hospital
Address:
City:
Miyagi
Zip:
981-0914
Country:
Japan
Status:
Recruiting
Facility:
Name:
Niigata University Medical & Dental Hospital
Address:
City:
Niigata
Zip:
951-8520
Country:
Japan
Status:
Completed
Facility:
Name:
Niigata University Medical & Dental Hospital
Address:
City:
Niigata
Zip:
951-8520
Country:
Japan
Status:
Active, not recruiting
Facility:
Name:
Okayama University Hospital
Address:
City:
Okayama
Zip:
700-8558
Country:
Japan
Status:
Recruiting
Facility:
Name:
Osaka Habikino Medical Center
Address:
City:
Osaka
Zip:
583-8588
Country:
Japan
Status:
Recruiting
Facility:
Name:
Saitama Cancer Center
Address:
City:
Saitama
Zip:
362-0806
Country:
Japan
Status:
Completed
Facility:
Name:
NHO Kinki-Chuo Chest Medical Center
Address:
City:
Sakai-shi
Zip:
591-8555
Country:
Japan
Status:
Recruiting
Facility:
Name:
CHA Bundang Medical Center
Address:
City:
Gyeonggi-do
Zip:
13496
Country:
Korea, Republic of
Status:
Withdrawn
Facility:
Name:
Seoul National University Bundang Hospital
Address:
City:
Seongnam-si
Zip:
463-707
Country:
Korea, Republic of
Status:
Withdrawn
Facility:
Name:
Seoul National University Hospital
Address:
City:
Seoul
Zip:
03080
Country:
Korea, Republic of
Status:
Active, not recruiting
Facility:
Name:
Severance Hospital
Address:
City:
Seoul
Zip:
03722
Country:
Korea, Republic of
Status:
Terminated
Facility:
Name:
Samsung Medical Center
Address:
City:
Seoul
Zip:
06351
Country:
Korea, Republic of
Status:
Terminated
Facility:
Name:
Asan Medical Center, Uni Ulsan Collegemedicine; Dept.Internal Medicine / Divisionhematology/Oncology
Address:
City:
Seoul
Zip:
138-736
Country:
Korea, Republic of
Status:
Terminated
Facility:
Name:
Asan Medical Center; Internal Dept / Gastorenterology
Address:
City:
Seoul
Zip:
138-736
Country:
Korea, Republic of
Status:
Completed
Facility:
Name:
Seoul National University College of Medicine, Liver Research Institute
Address:
City:
Seoul
Country:
Korea, Republic of
Status:
Active, not recruiting
Facility:
Name:
Pusan National University Yangsan Hospital; hemato-oncology
Address:
City:
Yangsan
Country:
Korea, Republic of
Status:
Withdrawn
Facility:
Name:
Riga's East Hosp Latvian Oncol; Medical Oncology
Address:
City:
Riga
Zip:
LV-1079
Country:
Latvia
Status:
Active, not recruiting
Facility:
Name:
Centro Universitario Contra El Cancer
Address:
City:
Monterrey
Zip:
64020
Country:
Mexico
Status:
Withdrawn
Facility:
Name:
Centro Medico Dalinde
Address:
City:
Mexico City
Zip:
06700
Country:
Mexico
Status:
Completed
Facility:
Name:
Phylasis Clinicas Research S de RL de CV; Sucursal Toluca
Address:
City:
Toluca de Lerdo
Zip:
50090
Country:
Mexico
Status:
Terminated
Facility:
Name:
Førde sentralsjukehus
Address:
City:
Førde
Zip:
6800
Country:
Norway
Status:
Withdrawn
Facility:
Name:
Szpital Specjalistyczny Podkarpacki O?rodek Onkologiczny
Address:
City:
Brzozów
Zip:
36-200
Country:
Poland
Status:
Active, not recruiting
Facility:
Name:
SP ZOZ Wojewódzki Szpital Specjalistyczny nr 4; Oddzial Onkologii Klinicznej
Address:
City:
Bytom
Zip:
41-902
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Uniwersyteckie Centrum Kliniczne; Klinika Onkologii i Radioterapii
Address:
City:
Gdansk
Zip:
80-214
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Przychodnia Lekarska KOMED, Roman Karaszewski
Address:
City:
Konin
Zip:
62-500
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Szpital Uniwersytecki w Krakowie, Oddzia? Kliniczny Kliniki Onkologii
Address:
City:
Kraków
Zip:
30-688
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie; Oddzial onkologii z pododdzialem chemioterapii
Address:
City:
Olsztyn
Zip:
10-357
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii
Address:
City:
Otwock
Zip:
05-400
Country:
Poland
Status:
Active, not recruiting
Facility:
Name:
Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy; Oddzial Iii
Address:
City:
Otwock
Zip:
05-400
Country:
Poland
Status:
Active, not recruiting
Facility:
Name:
Uniwersytecki Szpital Kliniczny w Poznaniu
Address:
City:
Pozna?
Zip:
60-780
Country:
Poland
Status:
Active, not recruiting
Facility:
Name:
Med-Polonia Sp. z o.o.
Address:
City:
Poznan
Zip:
60-693
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Narodowy Instytut Onkologii im. Marii Sk?odowskiej-Curie - Pa?stwowy Instytut Badawczy
Address:
City:
Warszawa
Zip:
02-781
Country:
Poland
Status:
Active, not recruiting
Facility:
Name:
Szpital Grochowski im. dr med. Rafa?a Masztaka Sp. z o.o.
Address:
City:
Warszawa
Zip:
04-073
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Centro Hospitalar do Porto ? Hospital de Santo António; Oncologia
Address:
City:
Porto
Zip:
4099-001
Country:
Portugal
Status:
Withdrawn
Facility:
Name:
Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca; Oncologie Medicala
Address:
City:
Cluj Napoca
Zip:
400015
Country:
Romania
Status:
Terminated
Facility:
Name:
Centrul de Oncologie Sfantul Nectarie
Address:
City:
Craiova
Zip:
200347
Country:
Romania
Status:
Active, not recruiting
Facility:
Name:
Institutul Regional de Oncologie Iasi; Clinica de Hematologie
Address:
City:
Iasi
Zip:
700483
Country:
Romania
Status:
Active, not recruiting
Facility:
Name:
Centrul de Oncologie Oncohelp
Address:
City:
Timisoara
Zip:
300239
Country:
Romania
Status:
Active, not recruiting
Facility:
Name:
Arkhangelsk Regional Clinical Oncology Dispensary
Address:
City:
Arkhangelsk
Zip:
163045
Country:
Russian Federation
Status:
Terminated
Facility:
Name:
Russian Oncology Research Center n.a. N.N. Blokhin
Address:
City:
Moscow
Zip:
115478
Country:
Russian Federation
Status:
Terminated
Facility:
Name:
P.A. Herzen Oncological Inst. ; Oncology
Address:
City:
Moscow
Zip:
125248
Country:
Russian Federation
Status:
Recruiting
Facility:
Name:
FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"
Address:
City:
Saint-Petersburg
Country:
Russian Federation
Status:
Completed
Facility:
Name:
Leningrad Regional Clinical Hospital
Address:
City:
St Petersburg
Zip:
194291
Country:
Russian Federation
Status:
Withdrawn
Facility:
Name:
Scientific Research Institute of Oncology n.a. N.N. Petrov; Department of Oncogynecology
Address:
City:
St. Petersburg
Zip:
197758
Country:
Russian Federation
Status:
Withdrawn
Facility:
Name:
Ivanovo Regional Oncology Dispensary; Chemotherapy Department
Address:
City:
Ivanovo
Zip:
153013
Country:
Russian Federation
Status:
Completed
Facility:
Name:
National University Hospital
Address:
City:
Singapore
Zip:
117599
Country:
Singapore
Status:
Completed
Facility:
Name:
University Hospital Bratislava; Department of Oncology
Address:
City:
Bratislava
Zip:
826 06
Country:
Slovakia
Status:
Active, not recruiting
Facility:
Name:
Narodny Onkologicky Ustav; Oddelenie klinickej onkologie A
Address:
City:
Bratislava
Zip:
833 10
Country:
Slovakia
Status:
Completed
Facility:
Name:
Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
Address:
City:
Sabadell
Zip:
8208
Country:
Spain
Status:
Completed
Facility:
Name:
Hospital Universitario Son Espases
Address:
City:
Palma de Mallorca
Zip:
07010
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Clínica Universidad de Navarra
Address:
City:
Pamplona
Zip:
31620
Country:
Spain
Status:
Completed
Facility:
Name:
Hospital Universitario Quiron Dexeus
Address:
City:
Barcelona
Zip:
08028
Country:
Spain
Status:
Active, not recruiting
Facility:
Name:
Hospital Universitari Vall d'Hebron
Address:
City:
Barcelona
Zip:
08035
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Hospital Clinic de Barcelona
Address:
City:
Barcelona
Zip:
08036
Country:
Spain
Status:
Active, not recruiting
Facility:
Name:
Hospital Lucus Augusti; Servicio de Oncologia
Address:
City:
Lugo
Zip:
27003
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Hospital General Universitario Gregorio Mara
Address:
City:
Madrid
Zip:
28009
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Clinica Universidad de Navarra-Madrid
Address:
City:
Madrid
Zip:
28027
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Centro Integral Oncologico Clara Campal; Servicio de Oncología
Address:
City:
Madrid
Zip:
28050
Country:
Spain
Status:
Withdrawn
Facility:
Name:
HM Sanchinarro ? CIOCC; Servicio de Oncologia
Address:
City:
Madrid
Zip:
28050
Country:
Spain
Status:
Active, not recruiting
Facility:
Name:
Hospital Regional Universitario Carlos Haya
Address:
City:
Malaga
Zip:
29010
Country:
Spain
Status:
Active, not recruiting
Facility:
Name:
Hospital Clinico Universitario de Valencia
Address:
City:
Valencia
Zip:
46010
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Hospital Clínico Universitario de Valencia; Medical Oncology
Address:
City:
Valencia
Zip:
46010
Country:
Spain
Status:
Completed
Facility:
Name:
Freiburger Spital; Onkologie
Address:
City:
Fribourg
Zip:
1708
Country:
Switzerland
Status:
Completed
Facility:
Name:
Chang Gung Memorial Hospital Chiayi
Address:
City:
Putzu
Zip:
613
Country:
Taiwan
Status:
Completed
Facility:
Name:
Taichung Veterans General Hospital
Address:
City:
Taichung
Zip:
40705
Country:
Taiwan
Status:
Completed
Facility:
Name:
Koo Foundation Sun Yat-Sen Cancer Center; Hemato-Oncology
Address:
City:
Taipei City
Zip:
11259
Country:
Taiwan
Status:
Completed
Facility:
Name:
Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
Address:
City:
Bangkok
Zip:
10700
Country:
Thailand
Status:
Recruiting
Facility:
Name:
Communal Non profit Enterprise Regional Center of Oncology; Oncosurgical dept of thoracic organs
Address:
City:
Kharkiv
Zip:
61070
Country:
Ukraine
Status:
Terminated
Facility:
Name:
Uzhhorod Central City Clinical Hospital
Address:
City:
Uzhhorod
Zip:
88000
Country:
Ukraine
Status:
Completed
Facility:
Name:
Municipal Institution Podilskiy Regional Center of Oncology; Department of Chemotherapy
Address:
City:
Vinnytsia
Zip:
21029
Country:
Ukraine
Status:
Completed
Facility:
Name:
MI of the Lviv Regional Council Lviv Oncology Regional Treatment and Diagnostic Centre; Chemotherapy
Address:
City:
Lviv
Zip:
79031
Country:
Ukraine
Status:
Withdrawn
Facility:
Name:
National Cancer Institute MOH of Ukraine
Address:
City:
Kiev
Zip:
36022
Country:
Ukraine
Status:
Terminated
Facility:
Name:
ME Kryviy Rih Oncology Dispensary of Dnipropetrovs?k Regional Council; Chemotherapy Department
Address:
City:
Kryvyi Rih
Zip:
50048
Country:
Ukraine
Status:
Terminated
Facility:
Name:
Volyn Regional Oncology Dispensary
Address:
City:
Lutsk
Zip:
43018
Country:
Ukraine
Status:
Active, not recruiting
Facility:
Name:
Regional Municipal Institution Sumy Regional Clinical Oncology Dispensary; Sumy State Uni, Med Inst
Address:
City:
Sumy
Zip:
40022
Country:
Ukraine
Status:
Terminated
Facility:
Name:
Barts Cancer Institute
Address:
City:
London
Zip:
E1 2AT
Country:
United Kingdom
Status:
Active, not recruiting
Facility:
Name:
St Georges University Hospitals NHS Foundation Trust
Address:
City:
London
Zip:
SW17 0RE
Country:
United Kingdom
Status:
Withdrawn
Start date:
February 28, 2019
Completion date:
July 5, 2028
Lead sponsor:
Agency:
Hoffmann-La Roche
Agency class:
Industry
Source:
Hoffmann-La Roche
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT03768063
